BAX vs. IBB

In the year-to-date period, BAX achieves a 8.45% return, which is significantly higher than IBB's -7.25% return. Over the past 10 years, BAX has underperformed IBB with an annualized return of 0.03%, while IBB has yielded a comparatively higher 0.31% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Baxter International Inc. (BAX) and iShares Nasdaq Biotechnology ETF (IBB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current BAX Sharpe Ratio is -0.26, which is higher than the IBB Sharpe Ratio of -0.45. The chart below compares the historical Sharpe Ratios of BAX and IBB, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

BAX's dividend yield for the trailing twelve months is around 2.92%, more than IBB's 0.31% yield.

The maximum BAX drawdown since its inception was -68.86%, which is greater than IBB's maximum drawdown of -62.85%. Use the drawdown chart below to compare losses from any high point for BAX and IBB. For additional features, visit the drawdowns tool.

The current volatility for Baxter International Inc. (BAX) is 8.52%, while iShares Nasdaq Biotechnology ETF (IBB) has a volatility of 10.16%. This indicates that BAX experiences smaller price fluctuations and is considered to be less risky than IBB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.